Home/Filings/4/0001567619-22-013453
4//SEC Filing

Payne Fletcher 4

Accession 0001567619-22-013453

CIK 0000882361other

Filed

Jun 27, 8:00 PM ET

Accepted

Jun 28, 4:16 PM ET

Size

5.7 KB

Accession

0001567619-22-013453

Insider Transaction Report

Form 4
Period: 2022-06-27
Payne Fletcher
SR VP & Chief Fin. Officer
Transactions
  • Award

    Common Stock

    2022-06-27+1,000,0001,000,000 total
    Exercise: $0.85Exp: 2032-06-26Common Stock (1,000,000 underlying)
Footnotes (1)
  • [F1]The options vest as follows: 50% of the options vest on 6/27/2023; the remaining options will vest in equal annual installments on June 27, 2024, June 27, 2025, and June 27, 2026.

Documents

1 file

Issuer

Aptose Biosciences Inc.

CIK 0000882361

Entity typeother

Related Parties

1
  • filerCIK 0001650476

Filing Metadata

Form type
4
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 4:16 PM ET
Size
5.7 KB